Medical Device Network on MSN
Neurovalens receives EU MDR compliance for sleep insomnia device
Achieving MDR compliance shows Modius Sleep meets safety, clinical, and quality standards required for entry into the EU market.
Modius Sleep is currently available via prescription in the US for $2,265 (£1,690) ...
A headset for treatment of insomnia which was developed by a company in Belfast has been approved for sale in Europe and the ...
Belfast-based neurotechnology company Neurovalens has received approval for its prescribed insomnia treatment from authorities in the European Union (EU) and the UK, clearing the way for its sale in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results